https://ir.opthea.com/static-files/bd59ddce-4c9c-46d1-82bf-790ed8b1f827
How did we miss this important and undoubtedly very positive update from last week’s JP Morgan San Francisco Healthcare Conference?!
From page 3 of the presentation:
„P3 clinical trials about 90% enrolled at the beginning of January 2024.
Anticipated patient enrollment: COAST 1Q2024, ShORe 2Q2024.
Topline data expected mid 2025.“
Given OPT‘s rather dire track record when it comes to meeting timelines, this is more than just a comforting bit of news.
The best possible scenario remains intact, that‘s reporting full enrollment BEFORE refinancing to get to top line read out.
Important milestone: 90% enrollment achieved, timeline confirmed!
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
55.0¢ |
Change
-0.040(6.78%) |
Mkt cap ! $364.5M | |||
| Open | High | Low | Value | Volume |
| 59.0¢ | 59.0¢ | 54.0¢ | $681.7K | 1.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 19334 | 54.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 55.0¢ | 31303 | 3 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
55.0¢ |
Change
-0.040 ( 6.78 %) |
||||
| Open | High | Low | Volume | ||
| 58.5¢ | 58.5¢ | 54.0¢ | 247548 | ||
| Last updated 15.59pm 29/05/2024 ? | |||||
| OPT (ASX) Chart |